Skip to main content

Bumrungrad Hospital Public Company Limited (BH.BK)

Stock Exchange of Thailand Healthcare Medical - Care FacilitiesView data quality →
60.8Fair

ValueMarkers Composite Index

Top 81%#8,550 of 44,707
Undervalued

70% below intrinsic value ($18)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.86
Low Risk
Altman
17.77
Safe
DCF Value
$18
Undervalued
ROIC
22.0%
Strong
P/E
18.3
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Bumrungrad Hospital Public Company Limited (BH.BK) — VMCI valuation read

Across 120 indicators, Bumrungrad Hospital Public Company Limited (BH.BK) lands at VMCI 61/100. The Healthcare sector median is 50, so the 11-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on BH.BK in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, BH.BK trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 2.2x is the rate-sensitivity line to watch for BH.BK on the trailing balance sheet.

BH.BK rose 1.8% over the trailing 7 days, with a -4.4% read on a 30-day basis.

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.

CEO: Artirat Charukitpipat27,987 employeesTHwww.bumrungrad.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BH.BK’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.